7月10日百济神州宣布欧盟委员会(EC)已批准百泽安(替雷利珠单抗)联合吉西他滨和顺铂用于不适合根治性手术或放疗的转移或

智通财经
10 Jul
7月10日百济神州宣布欧盟委员会(EC)已批准百泽安(替雷利珠单抗)联合吉西他滨和顺铂用于不适合根治性手术或放疗的转移或复发性鼻咽癌(NPC)成年患者的一线治疗。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10